An open label study assessing the absorption, metabolism, and excretion of single oral dose Tropifexor in healthy male subjects
Latest Information Update: 18 May 2021
At a glance
- Drugs Tropifexor (Primary)
- Indications Hepatic fibrosis; Liver disorders; Non-alcoholic steatohepatitis; Primary bile acid malabsorption; Primary biliary cirrhosis
- Focus Pharmacokinetics
- 18 May 2021 New trial record
- 05 May 2021 Results published in the Drug Metabolism and Disposition